Kidney Transplantation 360°

Conditions

Kidney transplantation Surgery Kidney transplantation

Sinem Karaterzi, Jenny Prüfe, Julia K. Wolff, Nele Kanzelmeyer, Thurid Ahlenstiel-Grunow et al. (12 authors)

Frontiers in Nephrology2025-06-12

10.3389/fneph.2025.1569116

A multimodal aftercare intervention improves the outcome after kidney transplantation - results of the KTx360° aftercare program using claims data.

Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, Gertges R, Schieffer E, Albrecht A, Boeck HT, Kliem V, Wolff JK, Ludolph P, Talamo J, Nolting HD, Lieb M, Erim Y, Krusemark H, Gefeller O, Kaiser I, Tegtbur U, Schiffer M, KTx360°-Study Group.

2024-05-257 citations

10.1016/j.eclinm.2024.102652

Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy

Katrin Birkefeld, Maximilian Bauer-Hohmann, Felix Klewitz, Eva-Marie Kyaw Tha Tun, Uwe Tegtbur et al. (10 authors)

Journal of Clinical Psychology in Medical Settings2022-02-235 citations

10.1007/s10880-022-09861-0

The KTx360°-study: a multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults.

Pape L, de Zwaan M, Tegtbur U, Feldhaus F, Wolff JK, Schiffer L, Lerch C, Hellrung N, Kliem V, Lonnemann G, Nolting HD, Schiffer M.

2017-08-2334 citations

10.1186/s12913-017-2545-0

Interventions

In addition to routine care, the patients receive the following interventions that are not included in routine care: Case management: This takes place over two years and involves continuous organiz

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving a kidney transplant between 2010 and 2019 in lower Saxony.

Exclusion criteria

Exclusion criteria: Insurance company does not take part in KTX360°

Design outcomes

Primary

Measure	Time frame
Health care costs due to hospitalization are measured using health insurance data at end of all interventions (12 or 24 months).	—

Secondary

Measure	Time frame
In all patients all endpoints will be evaluated 24 months after study start, taking into account that some patients will only have 12 months of interventions. 1. Adherence for outpatient visits is measured by actual visits/scheduled visits at end of all interventions 2. Adherence to immunosuppressive therapy is measured by BAASIS-Scale at each psychosocial assessment 3. Cardiovascular fitness and stabilization of weight is measured by different parameters at each CV-assessment 4. Quality of life is measured by Peds-QL and/or SF35 at each psychosocial assessment 5. Implementation of an internet-based case file including all sectors of care is assessed using case file at end of all interventions 6. Implementation and acceptance of telemedicine visits are measured using case file at end of all interventions	—

Measure

Time frame

In all patients all endpoints will be evaluated 24 months after study start, taking into account that some patients will only have 12 months of interventions. 1. Adherence for outpatient visits is measured by actual visits/scheduled visits at end of all interventions 2. Adherence to immunosuppressive therapy is measured by BAASIS-Scale at each psychosocial assessment 3. Cardiovascular fitness and stabilization of weight is measured by different parameters at each CV-assessment 4. Quality of life is measured by Peds-QL and/or SF35 at each psychosocial assessment 5. Implementation of an internet-based case file including all sectors of care is assessed using case file at end of all interventions 6. Implementation and acceptance of telemedicine visits are measured using case file at end of all interventions

—

Countries

Germany

Outcome results

None listed